Thompson Davis & Co’s Cambrex Corporation CBM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-1,000
Closed -$54K 1283
2016
Q4
$54K Sell
1,000
-1
-0.1% -$48 0.09% 227
2016
Q3
$45K Hold
1,001
0.08% 264
2016
Q2
$52K Hold
1,001
0.08% 233
2016
Q1
$44K Sell
1,001
-7,042
-88% -$278K 0.07% 265
2015
Q4
$379K Sell
8,043
-4,155
-34% -$200K 0.54% 35
2015
Q3
$484K Buy
12,198
+11,197
+1,119% +$524K 0.68% 22
2015
Q2
$44K Hold
1,001
0.05% 338
2015
Q1
$40K Sell
1,001
-500
-33% -$14.8K 0.05% 342
2014
Q4
$32K Sell
1,501
-250
-14% -$5.3K 0.04% 385
2014
Q3
$33K Hold
1,751
0.04% 359
2014
Q2
$36K Buy
1,751
+250
+17% +$5.08K 0.05% 300
2014
Q1
$28K Buy
1,501
+1,251
+500% +$24.1K 0.05% 340
2013
Q4
$5K Buy
+250
New +$4.32K 0.01% 571

Other funds holding CBM

Thompson Davis & Co's CBM Position: Q1 2017 in Review

Thompson Davis & Co sold out of Cambrex Corporation (CBM) in Q1 2017, closing a stake of 1,000 shares — an estimated $54K sold.

Thompson Davis & Co first reported a position in CBM in Q4 2013 and held it in 13 quarters. The position peaked at $484K in Q3 2015. 255 funds tracked by Wall St. Rank hold CBM as of Q1 2017.

  • Thompson Davis & Co reported no remaining Cambrex Corporation position as of Q1 2017 after selling out during the quarter.
  • Thompson Davis & Co sold 1,000 Cambrex Corporation shares in Q1 2017, an estimated $54K.
  • Thompson Davis & Co first reported a position in Cambrex Corporation in Q4 2013 and held it in 13 quarters.
  • Thompson Davis & Co's Cambrex Corporation position peaked at $484K in Q3 2015.
  • 255 funds tracked by Wall St. Rank held Cambrex Corporation as of Q1 2017.

Based on Thompson Davis & Co's 13F filing for Q1 2017, filed 8 May 2017.